Intramyocardial Injection of Stem Cells in Pig Myocardial Infarction Model: The First Trial in Korea.

Min Chul Kim, Yong Sook Kim, Wan Seok Kang, Ki Hong Lee, Meeyoung Cho, Moon Hwa Hong, Kyung Seob Lim, Myung Ho Jeong, Youngkeun Ahn
Author Information
  1. Min Chul Kim: Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea. ORCID
  2. Yong Sook Kim: Biomedical Research Institute, Chonnam National University Hospital, Gwangju, Korea. ORCID
  3. Wan Seok Kang: Biomedical Research Institute, Chonnam National University Hospital, Gwangju, Korea. ORCID
  4. Ki Hong Lee: Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea. ORCID
  5. Meeyoung Cho: Cell Regeneration Research Center, Chonnam National University Hospital, Gwangju, Korea. ORCID
  6. Moon Hwa Hong: Cell Regeneration Research Center, Chonnam National University Hospital, Gwangju, Korea. ORCID
  7. Kyung Seob Lim: Biomedical Research Institute, Chonnam National University Hospital, Gwangju, Korea. ORCID
  8. Myung Ho Jeong: Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea. ORCID
  9. Youngkeun Ahn: Department of Cardiology, Chonnam National University Hospital, Gwangju, Korea. ORCID

Abstract

Although cell therapy is emerged for cardiac repair, its efficacy is modest by intracoronary infusion. Therefore, we established the intramyocardial delivery technique using a left ventricular (LV) mapping system (NOGA® XP) using 18 pigs. After adipose tissue-derived mesenchymal stem cells (ATSCs) were delivered intramyocardially to porcine infarcted heart, LV ejection fraction (EF) was increased, and LV chamber size was decreased. We proved the therapeutic effect of intramyocardial injection of ATSC through a LV mapping system in the porcine model for the first time in Korea. The adoption of this technique may accelerate the translation into a clinical application in the near future.

Keywords

References

  1. Nat Clin Pract Cardiovasc Med. 2009 Jan;6(1):70-81 [PMID: 19002124]
  2. JAMA. 2014 Jan 1;311(1):62-73 [PMID: 24247587]
  3. Circ Res. 2011 Apr 1;108(7):792-6 [PMID: 21415390]
  4. Circ Res. 2011 Sep 30;109(8):923-40 [PMID: 21960725]
  5. J Am Soc Echocardiogr. 2005 Dec;18(12 ):1440-63 [PMID: 16376782]
  6. Thromb Haemost. 2010 Mar;103(3):564-71 [PMID: 20076851]
  7. Korean Circ J. 2011 Jul;41(7):363-71 [PMID: 21860637]
  8. N Engl J Med. 2010 Jan 21;362(3):228-38 [PMID: 20089973]
  9. J Am Coll Cardiol. 2013 Jun 11;61(23):2329-38 [PMID: 23583246]
  10. PLoS One. 2012;7(5):e37373 [PMID: 22655042]
  11. Am Heart J. 2011 Mar;161(3):487-93 [PMID: 21392602]
  12. Nat Rev Cardiol. 2011 May 17;8(7):393-404 [PMID: 21587214]
  13. J Cardiovasc Transl Res. 2010 Apr;3(2):160-8 [PMID: 20560030]
  14. Circ Res. 2015 Apr 10;116(8):1346-60 [PMID: 25700037]
  15. J Am Coll Cardiol. 2015 Apr 14;65(14):1454-71 [PMID: 25857912]
  16. BMC Cell Biol. 2013 Sep 11;14:38 [PMID: 24024790]

MeSH Term

Animals
Disease Models, Animal
Drug Administration Routes
Echocardiography
Heart
Mesenchymal Stem Cell Transplantation
Mesenchymal Stem Cells
Myocardial Infarction
Republic of Korea
Swine
Ventricular Function, Left

Word Cloud

Created with Highcharts 10.0.0LVintramyocardialtechniqueusingmappingsystemporcineKoreaStemMyocardialInfarctionAlthoughcelltherapyemergedcardiacrepairefficacymodestintracoronaryinfusionThereforeestablisheddeliveryleftventricularNOGA®XP18pigsadiposetissue-derivedmesenchymalstemcellsATSCsdeliveredintramyocardiallyinfarctedheartejectionfractionEFincreasedchambersizedecreasedprovedtherapeuticeffectinjectionATSCmodelfirsttimeadoptionmayacceleratetranslationclinicalapplicationnearfutureIntramyocardialInjectionCellsPigModel:FirstTrialHeartFailureMesenchymalCellTransplantation

Similar Articles

Cited By